 Clinical Oncology News | Study Gives Slight Edge to R-DHAP for B-Cell Lymphoma Subtype Clinical Oncology News When CORAL was first presented, not only were we disappointed that neither R-ICE nor R-DHAP proved superior, we were devastated to learn how poorly both regimens performed in patients who previously had been treated with rituximab. ... |
